potassium-competitive acid blockers (P-CABs) are a class of medications which suppress gastric acid secretion apparently with more rapid and consistent acid suppression, negligible CYP2C19 interaction, longer half-life, and high tolerability than with
proton pump inhibitors (PPIs)